首页 | 本学科首页   官方微博 | 高级检索  
检索        

依拉普利联合安体舒通对慢性心力衰竭患者血浆脑钠肽影响
引用本文:陈良余,黎敬锋,李世光,王厚阳,陆明奎,谢瑞玉,王超,蔡大炜,张素明,周扬,李银,费亮,牛杰,朱章进,倪训业.依拉普利联合安体舒通对慢性心力衰竭患者血浆脑钠肽影响[J].吉林医学,2010,31(7):885-887.
作者姓名:陈良余  黎敬锋  李世光  王厚阳  陆明奎  谢瑞玉  王超  蔡大炜  张素明  周扬  李银  费亮  牛杰  朱章进  倪训业
作者单位:安徽滁州市第二人民医院;
基金项目:安徽省滁州市政府社科基金资助项目(编号:200750)
摘    要:目的:探讨慢性充血性心力衰竭(CHF)患者在常规加用依拉普利治疗基础上联合安体舒通治疗对血浆脑钠肽(BNP)的影响。方法:将CHF患者68例随机分为两组:依拉普利组35例,依拉普利加安体舒通组33例,治疗观察时间均为24周。检测治疗前后两组患者的血压、血浆BNP水平、超声心动图等。结果:治疗24周后,两组患者血浆BNP水平、超声心动图与治疗前比较有统计学意义(P<0.05)。治疗后两组间血浆BNP水平比较有统计学意义(P<0.01)。结论:依拉普利与安体舒通均能改善患者心功能、降低血浆BNP水平,两药联合治疗更明显。

关 键 词:心力衰竭  B型脑钠肽  依拉普利  安体舒通

Comparison of effects of Enalapril and spironolactone on natriuretic peptide in patients with chronic heart failure
CHEN Liang-yu,LI Jing-feng,LI Shi-guang,et al.Comparison of effects of Enalapril and spironolactone on natriuretic peptide in patients with chronic heart failure[J].Jilin Medical Journal,2010,31(7):885-887.
Authors:CHEN Liang-yu  LI Jing-feng  LI Shi-guang  
Institution:CHEN Liang-yu,LI Jing-feng,LI Shi-guang,et al(The Second People′s Hospital of Chuzhou City,Chuzhou 239000,China)
Abstract:Objective To evaluate the effects on brain natriuretic peptide(BNP) of patients with chronic congestive heart failure(CHF) with the basic Enalapril therapy plus spironolactone.Method Total 68 patients with CHF were randomly divided into two groups:Thirty-five patients in Enalapril group,thirty-three patients in Enalapril and spironolactone group.The treatment duration was 24 weeks.Blood pressure,plasma BNP level,echocardiography were tested before and after treatment in the two groups.Results After 24 weeks...
Keywords:Heart failure  B-type natriuretic peptide  Enalapril  Spironolactone  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号